Ticagrelor
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ticagrelor and local guidelines before prescribing.
Mechanism
Reversible P2Y12 receptor antagonist.
Uses
Acute coronary syndrome, post-MI secondary prevention.
Dosing
- Ticagrelor (90 mg twice daily) - reversible, more potent; side effects - breathlessness , bradyarrhythmias; interacts with strong CYP3A4 drugs.
Cardiology: Anatomy Physiology and Pharmacology - Second antiplatelet (per local PPCI protocol): prasugrel (60 mg loading, then 10 mg daily; 5 mg if aged 75 or over or under 60 kg) if not on an oral anticoagulant, or ticagrelor (180 mg loading, then 90 mg twice daily). Clopidogrel if high bleeding risk or on an anticoagulant.
Cardiology: Cardiology Emergencies - Ticagrelor ACS | 180 mg loading, then 90 mg twice daily.
Cardiology: Cardiology Emergencies - Clopidogrel: 300 mg loading if aged 75 or under; 75 mg (no loading) if over 75; then 75 mg daily. Ticagrelor and prasugrel are not used with fibrinolysis.
Cardiology: Ischaemic Heart Disease (ACS) › 1.21 STEMI: Fibrinolysis
2 more dose entries from the chapters
- Ticagrelor | 180 mg loading, then 90 mg twice daily for 12 months; 60 mg twice daily thereafter in selected patients.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
Clinical pharmacology and prescribing: Principles of clinical pharmacology
Side effects
Bleeding, dyspnoea, bradycardia, raised uric acid and creatinine.
Interactions
Strong CYP3A4 inhibitors and inducers; simvastatin dose limit.
Contraindications and cautions
Active bleeding, prior intracranial haemorrhage, severe liver disease
Monitoring
Bleeding, dyspnoea
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
No adjustment
Overdose and reversal
Platelet transfusion not effective; supportive
Special advice
Dyspnoea is usually benign; avoid in prior intracranial haemorrhage; hold before surgery per guidance.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Before surgery - clopidogrel and ticagrelor usually stopped 5 days, prasugrel 7 days before (balance against stent thrombosis - discuss with cardiology).
Cardiology: Anatomy Physiology and Pharmacology - PCI planned: Prasugrel or ticagrelor.
Cardiology: Cardiology Emergencies - Conservative management: Ticagrelor (or clopidogrel if high bleeding risk).
Cardiology: Cardiology Emergencies - STEMI with primary PCI: Prasugrel with aspirin if not on an oral anticoagulant; ticagrelor or clopidogrel as alternatives depending on bleeding risk.
Cardiology: Ischaemic Heart Disease (ACS) › 1.23 Antiplatelet Therapy - NSTEMI or unstable angina having angiography: Prasugrel or ticagrelor. Give prasugrel only once the anatomy is known and PCI is planned.
Cardiology: Ischaemic Heart Disease (ACS) › 1.23 Antiplatelet Therapy
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (5 mentions)
- Cardiology: Cardiology Emergencies (4 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (5 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Investigations (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (6 mentions)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Surgery: Surgical principles and perioperative care (2 mentions)
- Surgery: Cardiothoracic, neurosurgery and plastic surgery (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical imaging: Imaging pathways and interventional radiology (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (3 mentions)
- Integrated cardiology chapter (5 mentions)
- Pathology: Haemodynamic disorders, thrombosis, embolism and atherosclerosis (1 mention)